Triglyceride-mediated influence of serum angiopoietin-like protein 8 on subclinical atherosclerosis in type 2 diabetic patients: results from the GDMD study in China

Table 2 Correlations analysis of variables associated with circulating ANGPTL8 levels in control subjects with normal glucose tolerance (NGT), T2DM patients without atherosclerosis and T2DM patients with atherosclerosis

	Control subjects with NGT		T2DM without atherosclerosis		T2DM with atherosclerosis
	r	P	r	P	r	P
Age	0.188	0.061	0.330	0.001	0.206	0.039
BMI	0.000	0.997	− 0.029	0.778	0.235	0.018
SBP^a	− 0.031	0.763	− 0.042	0.686	0.106	0.301
DBP^a	0.126	0.218	0.033	0.746	− 0.037	0.723
TG^a	0.141	0.169	0.379	< 0.001	0.406	< 0.001
TC^a	− 0.055	0.596	0.020	0.848	0.083	0.419
LDL-C^a	− 0.032	0.755	0.040	0.696	− 0.050	0.625
HDL-C^a	− 0.144	0.158	0.088	0.392	0.075	0.466
Fasting plasma glucose^a	0.127	0.216	0.087	0.395	− 0.009	0.932
Fasting insulin^a	− 0.076	0.461	0.106	0.301	0.187	0.067
HOMA-IR^a	− 0.028	0.789	0.114	0.265	0.160	0.117
HbA1c^a	0.025	0.810	0.150	0.143	− 0.120	0.243
Duration of diabetes^a	–	–	0.250	0.013	0.306	0.002
c-IMT (mm)^a	0.101	0.324	0.340	0.001	0.336	0.001

^aP value determined by partial correlation analysis (age, sex, and BMI adjusted)

ISSN: 1475-2840